Kalaris Therapeutics Inc
$3.92
-0.12 (-2.97%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- -3.2%
- 3 Months
- -15.7%
- YTD
- -53.6%
- 1 Year
- -3.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 106.3%
- Largest decline max drawdown, since Aug 2025
- -69.6%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.48
Own KLRS?
See how KLRS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.